Pharmacogenomics: Tailoring drug therapies for improved outcomes

While research from as far back as the 1960's indicates that genetic variations are directly responsible for different medication responses, only recently have the reduced costs of testing made the benefits of pharmacogenomics (PGx) available to many patients. While the list of clinical trials and PGx tests is continually expanding, many medications are not yet associated with clinically useful guidance.

Download White Paper

You may also like:

Blog Post

An outbreak of coronavirus in Wuhan, China, has captured international attention, killing 82 in China (as of January 27 reports)...

View Blog Post
Blog Post

Heading into 2020, community-based pharmacies are focusing on patient-facing services and care as a way to achieve a variety of organizational and business goals. To that end, Drug Store News hosted as Industry Issues Summit in...

View Blog Post
Blog Post

Recent news from the Centers for Disease Control and Prevention (CDC) confirmed what circulating news reports were predicting: an early onset flu season. What remains to be...

View Blog Post

Filter by Type

Sign up to receive the latest news and information!

Sign Up